Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia

NCT02101853 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

669

Enrollment

NIH

Sponsor class

Conditions

Recurrent B Acute Lymphoblastic Leukemia

Interventions

PROCEDURE: Allogeneic Hematopoietic Stem Cell Transplantation
DRUG: Asparaginase
BIOLOGICAL: Blinatumomab
DRUG: Cyclophosphamide
DRUG: Cytarabine
DRUG: Dexamethasone
DRUG: Etoposide
DRUG: Leucovorin Calcium
DRUG: Mercaptopurine
DRUG: Methotrexate
DRUG: Mitoxantrone
DRUG: Mitoxantrone Hydrochloride
DRUG: Pegaspargase
OTHER: Pharmacological Study
RADIATION: Radiation Therapy
DRUG: Therapeutic Hydrocortisone
DRUG: Thioguanine
DRUG: Vincristine
DRUG: Vincristine Sulfate

Sponsor

National Cancer Institute (NCI)